CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery

CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery

<p>Abstract</p> <p>Background</p> <p>There is no consensus regarding the management of ovarian cancer patients, who have shown complete clinical response (CCR) to primary therapy and have rising cancer antigen CA-125 levels but have no symptoms of recurrent disease. The...

Full description

Bibliographic Details
Main Authors: Wang Fang, Ye Yanfen, Xu Xia, Zhou Xuehui, Wang Jinhua, Chen Xiaoxiang
Format: Article
Language:English
Published: BMC 2013-02-01
Series:Journal of Ovarian Research
Subjects:
Epithelial ovarian cancer
CA-125
Tumor marker
Clinical relapse
Cytoreductive surgery
Online Access:http://www.ovarianresearch.com/content/6/1/14

Internet

http://www.ovarianresearch.com/content/6/1/14

Similar Items